Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

67375 Press Releases
DateTitleCompany
13 Dec 11 BioLineRx to Develop and Commercialize Novel Peptide Drug Candidates Discovered by Compugen BioLineRx Ltd. and Compugen Ltd.,
Published by
Business Wire
13 Dec 11 RBCC to Join With Life Science Research Group BioHouston Rainbow Coral Corp.,
Published by
Business Wire
13 Dec 11 Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing Catabasis Pharmaceuticals,
Published by
Business Wire
13 Dec 11 InVivo Therapeutics’ CEO Frank Reynolds to Appear on Baltimore Sunday Morning News Show InVivo Therapeutics Holdings Corp.,
Published by
Business Wire
13 Dec 11 Targeted antibody treatment approach gives new hope for patients with rarer blood cancer Roche
13 Dec 11 Plasticell wins further Technology Strategy Board funding for £1.5m stem cell manufacturing project Plasticell
13 Dec 11 Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie Synergy Pharmaceuticals Inc.,
Published by
Business Wire
13 Dec 11 Final Data from Phase II Multi-Center Study Evaluating Combination of VIDAZA® and REVLIMID® in Higher-Risk MDS Patients Presented at ASH Celgene International Sàrl,
Published by
Business Wire
13 Dec 11 Phase II Study Evaluates Clinical Benefit of Pomalidomide in Heavily Pre-Treated Patients with Multiple Myeloma Celgene International Sàrl,
Published by
Business Wire
13 Dec 11 Phase II Study of ISTODAX® in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL): A Sub-Analysis of Patients with Most Common Subtypes of PTCL Presented at ASH Celgene International Sàrl,
Published by
Business Wire
13 Dec 11 Study Determines FFR Can Improve Health while Reducing Economic Burden to Belgian Health Care System St. Jude Medical Inc.,
Published by
Business Wire
13 Dec 11 Quintiles Launches China CRO, Kun Tuo Quintiles,
Published by
Business Wire
13 Dec 11 Benlysta Continues to Gain Increased Market Share among U.S. Rheumatologists Six-Months Post-Launch, According to a Recent BioTrends Report BioTrends Research Group,
Published by
Business Wire
13 Dec 11 Anacor Pharmaceuticals Announces Positive Preliminary Results from Phase 2a Trial of AN2728 and AN2898 in Atopic Dermatitis Anacor Pharmaceuticals,
Published by
Business Wire
13 Dec 11 Pfizer Elects CEO Ian Read As Chairman Of The Board Pfizer Inc.,
Published by
Business Wire
13 Dec 11 Lannett Receives FDA Approval for Triamterene with Hydrochlorothiazide 37.5/25mg Capsules Lannett Company Inc.,
Published by
Business Wire
13 Dec 11 Symphogen Presents Positive Rozrolimupab (SYM001) Phase 2 Trial Results in ITP at ASH Symphogen,
Published by
Business Wire
13 Dec 11 Overall Survival Benefit with VELCADE® Based Therapy in Previously Untreated Multiple Myeloma Patients Maintained After Five Year Follow-Up Millennium: The Takeda Oncology Company,
Published by
Business Wire
13 Dec 11 iCAD Announces Distribution Agreement with Carestream for MR Image Analysis and Mammography CAD iCAD Inc.,
Published by
Business Wire
13 Dec 11 First U.S. cell-based flu vaccine plant set for dedication U.S. Department of Health and Human Services,
Published by
Business Wire
13 Dec 11 Enzo Biochem Reports Fiscal First Quarter 2012 Results Enzo Biochem Inc.,
Published by
Business Wire
13 Dec 11 Phase III Study with REVLIMID® Continuous Therapy Demonstrates Statistically Significant Improvement in Progression-Free Survival for Patients Newly Diagnosed with Multiple Myeloma Celgene International Sàrl,
Published by
Business Wire
13 Dec 11 Univision, HolaDoctor and EnvisionRxOptions Partner to Launch Exclusive Prescription Savings Program Univision Enterprises,
Published by
Business Wire
13 Dec 11 Napo Terminates Glenmark Pharmaceuticals for Failure to Commercially Develop Crofelemer Napo Pharmaceuticals Inc.,
Published by
Business Wire
13 Dec 11 New Data Confirm Hemolysis as Predictor of Thromboembolism and Early Death in Patients with PNH and Demonstrate Need To Test High-Risk Patients for PNH Alexion Pharmaceuticals Inc.,
Published by
Business Wire
13 Dec 11 Ligand Announces Positive Preclinical Data on Small-Molecule GCSF Receptor Agonist at the 53rd Annual Meeting of the American Society of Hematology Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
13 Dec 11 Second Self Medicated Medical Cannabis Cancer Patient Reports Cannabis Science Brand Extracts Killing Cancer Cells  Cannabis Science Inc.,
Published by
Business Wire
13 Dec 11 Avila Therapeutics Presents Data on AVL-292, a Selective Bruton’s Tyrosine Kinase Inhibitor, for the Treatment of B Cell Cancers at the 2011 ASH Annual Meeting Avila Therapeutics Inc.,
Published by
Business Wire
13 Dec 11 Seattle Genetics and Millennium Highlight Pivotal Data on ADCETRIS™ (Brentuximab Vedotin) in Relapsed or Refractory Systemic ALCL at ASH Annual Meeting Seattle Genetics Inc.,
Published by
Business Wire
13 Dec 11 Seattle Genetics Reports Data From Multiple Presentations on ADCETRIS™ (Brentuximab Vedotin) at ASH Annual Meeting Seattle Genetics Inc.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.